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32 Abstract
33 Obesity caused by excessive deposited fat, is generally classified as body mass index (BMI) ≥30
34
2
kg/m . Research regarding the association between dietary advanced glycation end products
35 (dAGEs) and obesity is limited. The aim of present study was to investigate the association
36 between dAGEs and obesity and body composition in Iranian adults. This cross-sectional study
37 included 265 adults aged 18-75 years from Tehran, Iran. Dietary AGEs was estimated using a
38 validated semiquantitative food frequency questionnaire, according to the published food CML–
39 AGE database for 549 routine consumed food items for the Northeastern American multiethnic
40 urban population and was reported by dividing to total energy intake. Dietary intake, socio-
41 demographic data and physical activity status were collected using validated questionnaires and
42 anthropometric characteristics were measured. Body composition was assessed by bioelectrical
43 impedance analysis (BIA) and obesity was defined based on world health organization (WHO)
44 guidelines. The intake of fat and meat were significantly increased in higher tertiles, compared to
45 the first tertile of dAGEs (P <0.001). No association between dAGEs and body composition
46 measures and obesity was observed, however, there were a significant association between
47 dAGEs and BMI (body mass index; P=0.01), WC (waist circumference; P=0.01), WHR (waist-
48 to-hip ratio; P=0.03), FFM (fat free mass; P=0.02) and MMI (muscle mass index; P=0.01) in
49 nonlinear models. In conclusion, higher consumption of dAGEs was associated with increased
50 intake of fat and meat and was related to changes in body composition measurements. Therefore
51 dAGEs may connect obesity to diet by energy imbalance.
52
53
54
55
56
57
58
59
60
61
62
Introduction
Obesity, defined as abundant and abnormal accumulation of fat in the body, has negative, long-
(1)
term, effects on health . This chronic disease is a serious concern in developed and developing
    
    
   
  
 
  
 
  
 
   
 
   
 
   
 
  
 
   
  
 
  
 
  
 
   
  
 
  
 
  
 
   
 
    
 
    
 
   
 
  
 
   
 
   
 
 
 
 
 
    
  
   
 
   
  
 
  
 
  
 
 
 
  
 
  
 
  
 
  
 
(1-3)
66 countries . According to the SURFNCD-2007 , the prevalence of obesity and central obesity
(4)
67 was 22.3% and 53.6% respectively in Iran and WHO results showed that more than half of
(5)
68 Iranian adults were overweight and obese in 2010 .Obese people are exposed to various
69 illnesses, such as cardiovascular disease (CVD), gastrointestinal disorders, type 2 diabetes
70 (T2D), joint and muscular disorders, respiratory problems, and psychological issues, which have
(6)
71 significant effects on quality of life ,and increases the risk of early mortality . Obesity is
72 regarded as a multifactorial disorder that involves genetics, hormonal, metabolic, and behavioral
(7)
73 aspects . Nutritional changes, particularly towards high energy and high fat diets and decreased
74 physical activity, are some of the most important factors in increasing the prevalence of obesity
(8-10)
75 . Although Iranian dietary pattern is mainly contains carbohydrate (65%) specially bread and
(11)
76 white rice , interest in processed foods high in fat and sugar as an indicator of a lifestyle
77 characterized by urbanization and not to have enough time to prepare food, has been increased in
78 recent years. More than 300,000 deaths, annually reported in the United States are attributed to
(12)
79 poor nutritional behaviors, physical inactivity and obesity related issues , and thus, the
(13) 
80 importance of nutritional behaviors and consequential obesity is a serious concern .
81 Advanced glycation end products (AGEs) are compounds obtained from nonenzymatic reactions
(14)
82 between reducing sugars and free amino groups in proteins, lipids, or nucleic acids . AGEs
83 can cause oxidative stress and chronic inflammation when they bind their receptors that are
(15)
84 present in epithelial, immune, and endothelial cells . In addition to AGE endogenous
85 formation, the diet also affects the amount of bodily AGE, where it has been reported that 10%
(16)
86 of a high AGE diet will be absorbed . Foods with high amounts of fat and meat are considered
(17)
87 high in AGE, especially if cooked with dry heat . It has been shown that increasing the food
(18) 
88 AGEs leads to weight gain, and decreased insulin sensitivity and albumin excretion .
89 Moreover, studies have also shown the effect of receptor for advanced glycation end products
90 (RAGE) on weight gain, abdominal obesity, adipocyte size, development of CVD and insulin
(14, 19, 20)
91 resistance . Carboxymethyl lysine (CML), which is the main type of AGEs in the diet, is
(21)
92 typically used as a dietary AGE marker . Controversial data exist regarding the effects of
93 dietary AGEs on its circulating levels. Indeed, the results of some studies emphasize that intakes
(22)
94 of CML can lead to excess serum AGE levels , whereas others show no effect of dietary
(23)
95 AGEs on circulating levels of AGEs . Few studies have reported on the relationship between
96 intake of dietary AGEs and chronic disease, such as kidney disease, metabolic syndrome, and
97 cardiovascular disease. Thus, in the present study, we sought to investigate the relationship
98 between dietary AGEs and obesity and body composition in Iranian adults.
99 Methods
100 Study population
101 This cross sectional study was conducted on 265 subjects, aged 18-75 years, recruited by way of
102 convenience sampling. Inclusion criteria was; aged 18-75 years old and to be willing to
  
 
  
 
   
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
  
 
 
 
  
 
  
 
    
 
 
 
 
 
 
  
 
  
 
  
 
  
 
      
 
   
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
103 participate in this study, whilst exclusion criteria included extreme values of dietary intake (less
104 than 800 kcal/d or more than 4200 kcal/d, respectively), suffering from kidney, liver and lung
105 diseases and other conditions affecting the cardiovascular or respiratory system health, or,
106 infectious and active inflammatory diseases, pregnancy, lactation, routine supplement or drug
107 use, such as weight loss, hormonal, sedative drugs, thermogenic supplements like caffeine and
108 green tea, conjugated linoleic acid (CLA) etc. and the final analysis was conducted in 265
109 participants.
110 Dietary assessment
111 To record participant’s consumption frequency for each food item, during the past year, on a
112 daily, weekly, or monthly basis, was recorded by trained dietitians using a validated semi-
113 quantitative food frequency questionnaire (FFQ), which contains 168 food items. The reliability
(24) 
114 and validity of the FFQ for food group intakes has been assessed and found to be acceptable .
115 The reported amounts were converted to grams per day by the manual for household measures
116 book. Then, participant’s nutrients consumption was analyzed by Nutritionist IV software.
117 The most important type of dietary AGEs, Carboxymethyl lysine (CML), is usually used as a
(21)
118 dietary AGE marker . Because the Iranian Food Composition Table (FCT) does not detail
119 AGEs content, we collected data from the published food CML–AGE database for 549 routine
120 consumed food items for the Northeastern American multiethnic urban population, which was
(17, 21)
121 assessed by validated immunoassay method . We calculated CML–AGE values per day,
122 according to kilo unit (kU) amounts in 100 g solid food or 100 ml liquid for 151 out of 168 food
123 items in the validated FFQ list were determined by this database. The values for some Iranian
124 specific food items, e.g. some kinds of bread and cookie like Sangak,Lavash,Pirashki that there
125 are not in table, were estimated from similar food items and 17 items that had not similar food
126 like some kinds of confectionaries for example: Gaz, Noghl, Sohan were considered as missing.
127 Because AGEs amounts were not available for all fruits and vegetables, in this instance, we
(25)
128 considered the mean values of comparable fruits and vegetables . To make the AGEs intake
129 assessment independent of energy, these amounts were divided by total energy intake and
130 considered as dAGEs/EI that were categorized by tertile cutoffs (<2.96, 2.96 – 4.45 and 4.45< ).
131 Data Collection
132 According to inclusion and exclusion criteria, subjects were chosen and interviewed to collect
133 data on demographics, smoking status, physical activity, diet, and supplement use. Then,
134 anthropometric assessment was conducted. We used short form of International Physical Activity
135 Questionnaire (IPAQ) to assess the physical activity of the participants during the preceding
(26)
136 week . According to the IPAQ criteria, data were recorded regarding vigorous and moderate
137 activity and walking, for at least 10 min/day during the previous 7 days. Duration and frequency
  
 
  
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
   
 
  
 
    
 
  
 
  
 
  
 
  
 
  
 
   
 
 
 
  
 
  
 
  
 
   
 
  
 
  
 
   
 
  
 
   
 
  
 
   
 
    
 
  
 
    
 
   
 
  
 
    
 
   
 
  
138 of activity days were multiplied by the metabolic equivalent task value of the activity to calculate
139 the activity. The total physical activity per week was used to calculate the sum of the scores, and
140 categorized into three groups: low, moderate, and high. Also, IPAQ was computed for a
141 continuous score and reported as metabolic equivalent (MET)-minutes per week.
142 Subjects’ weight was recorded while wearing light clothing and unshod, to the nearest 0.1 kg,
143 using digital scales (Seca 808, Germany). Height was measured to the nearest 0.1 cm using a
144 stadiometer (Seca 206, Germany), in standing position, unshod. BMI was calculated as weight
145 (kg) divided by square of height (m
2
). WC was measured between lower rib and iliac crest, at the
146 widest portion, with light clothing, using a tape meter (Seca 201, Germany) without any pressure
(27) 
147 to the body . WHR was calculated as waist circumference (cm) divided by hip circumference
148 (cm). Blood pressure was measured twice, in a seated position following a 10-15 minute rest,
149 using a digital sphygmomanometer (Beurer, BC 08, Germany), and the mean of the two
150 measurements was considered as the participant’s systolic and diastolic blood pressure.
151 We used BIA (InBody S10, JMW140, Korea) to assess visceral fat level (VFL), skeletal muscle
152 mass (SMM), body fat percentage (PBF), body fat mass (BFM), fat free mass (FFM), and trunk
153 fat (TF). For increased accuracy, participants were advised to refrain from moderate and intense
154 exercises 1-2 hour before using BIA and to urinate before testing. Muscle mass index (MMI) was
155 calculated as skeletal muscle mass (kg) divided by height square (m
2
).
156 Obesity definition
157 General obesity was defined as BMI ≥30 kg/m2, whilst WC≥102 cm for men and ≥88cm for
158 women, and, WHR>0.9 for men and >0.85 for women were used as central obesity risk factors
(28)
159 . We then used median to categorize the VFL and BFM in two groups.
160 Statistical analysis
161 Analysis was conducted on 265 subjects. Participants were categorized based on the tertiles of
162 the AGEs. For comparison of the participant characteristics among the AGEs tertiles, one-way
163 analysis of variance (ANOVA) and chi-square tests were used for quantitative and qualitative
164 variables, respectively. Analysis of variance (ANOVA) was performed to report dietary intakes
165 of participants across the tertiles of the AGEs. We used ANOVA in crude models and ANCOVA
166 in adjusted models for age, sex, physical activity, smoking status, education status, metabolic
167 diseases  and  energy  intake to  investigate the association of dietary  AGE  intake  and
168 anthropometric measures and body composition.
169 According to WHO guidelines, BMI ≥ 30 kg/ m2 was used to classify general obesity, and
170 WC≥102 cm for men and ≥88cm for women and WHR>0.9 for men and >0.85 for women were
(28)
171 considered as markers of central obesity . Odds ratios and 95% confidence intervals were
172 obtained using logistic regression to determine the relationship of the AGEs and risk of obesity.
173 Logistic regression models included a dichotomous outcome (general obesity (yes or no) or
174 central obesity (yes or no)) and AGEs as exposure. The risk was reported in crude and 3 adjusted
 
  
 
  
 
   
 
   
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
 
 
 
 
 
  
 
  
 
  
 
   
 
  
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
175 models for age, sex, physical activity, smoking status, education status, metabolic diseases and
176 energy intake. In this analysis, the first tertile of exposure was considered as the reference
177 category. Nonlinear regression was conducted to investigate nonlinear associations between
178 AGEs and body composition measurements. We accepted statistical significance, a priori, at P<
179 0.05. We used SPSS version 22 (IBM) for all analyses.
180 Ethical approval
181 This study was conducted according to the guidelines laid down in the Declaration of Helsinki
182 and all procedures involving human subjects were approved by the ethics committee of Tehran
183 University of Medical Sciences (ethics Number: IR. TUMS.VCR.REC. 1398.503). Written
184 informed consent was obtained from all subjects.
185 Results
186 The mean±SD of age and BMI of the participants (44.1% male) were 36.6±13.1 years and
187 25.6±4.69kg/m
2
, respectively. The mean dAGEs/EI was 4.05 ± 1.83 kU/kcal (3.83 kU/kcal in
188 men and 4.23 kU/kcal in women). The mean consumption of AGEs in each tertile was 2.37, 3.67
189 and 6.13 respectively. Also, the results of dAGEs did not dependent on energy intake.
190 Demographic characteristics of all 265 participants across tertiles of AGEs are shown in Table
191 1.The distribution of the age and height in the tertiles of dAGEs was significant, so that
192 participants in the higher tertile were younger (P=0.003) and taller (P=0.02). Subjects in the
193 lowest compared with the highest tertile of AGEs had significantly more history of metabolic
194 diseases (P=0.003). Other participants’ characteristics were not related to intake of dAGEs.
195 Dietary intakes of participants according to tertiles of dietary AGE intakes are presented in
196 Table 2. The percentage of fat intake and meat consumption were significantly higher in
197 participants with the highest, compared to the lowest consumption of AGEs (P <0.001). In
198 addition, there was a significant decreasing trend in the percentage of carbohydrate intake across
199 the increasing trend of AGE consumption (P <0.001) and the most intake of protein was related
200 to second tertile of AGEs (P<0.001). However, there was no significant difference in energy
201 intake and fiber consumption across tertiles of AGE consumption. We also re-analyzed data
202 based on sex and found that results remained unchanged (Supplementary Table 1).
203 Table 3 shows the association between dietary AGEs intake and anthropometric measures and
204 body composition. There were not significant associations between BMI (P=0.09), WC(P=0.10),
205 WHR(P=0.20), VFL(P=0.35), SMM(P=0.23), PBF(P=0.89), BFM(P=0.22), FFM(P=0.14), MMI
206 (P=0.13) and TF (P=0.23) and AGEs intake before and after adjustment for possible confounders
207 such as age, sex, physical activity, smoking status, education status, metabolic diseases and
208 energy  intake.  Analyses according to the  sex  showed that results  remained  unchanged
209 (Supplementary Table 2).
   
 
    
  
 
    
 
   
 
  
 
 
   
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
   
 
    
 
  
 
  
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
    
 
  
 
   
 
  
 
  
 
  
 
   
 
  
 
  
 
   
210 The results of linear and nonlinear models association between AGEs intakes and body
211 composition measures are presented in Figure 1. In linear models, with increases in AGEs
212 intake, significant decrease in BMI (Plinearity=0.04), WC (Plinearity=0.03), FFM (Plinearity=0.02) and
213 MMI  (Plinearity=0.03) were observed.  In nonlinear  models,  BMI (Pnonlinearity=0.01), WC
214 (Pnonlinearity=0.01), WHR (Pnonlinearity=0.03), FFM (Pnonlinearity=0.02) and MMI (Pnonlinearity=0.01)
215 were significantly decreased along with increased AGEs intake.
216 Odd ratios and 95% confidence interval for general and central obesity in each tertile category of
217 AGEs intake are presented in Table 4. The association between AGE consumption and central
218 obesity that measured by waist circumference (p=0.05), waist to hip ratio (p=0.83) and body fat
219 mass (p=0.07), were not statistically significant after controlling for confounders. However, the
220 odds of central obesity assessed by VFL had decreasing trends across increasing tertiles of AGEs
221 intake in model 2 (P=0.03) and model 3 (P=0.03).Also, risk of general obesity was not
222 significantly different across tertiles of AGEs intake.
223 Discussion
224 We found that there was no association between intake of AGEs, body composition and odds of
225 central and general obesity. However, the relation between BMI, WC, WHR, FFM and MMI and
226 intake of AGEs in the nonlinear model were significant. Moreover, higher intake of AGEs was
227 associated with higher intake of fat and meat and lower intake of carbohydrate considering that
228 mentioned findings were independent of total energy intake. Re-analyzing data based on sex also
229 did not change our findings.
230 An important finding of the present study was that higher intake of AGEs was not related to
231 general and central obesity. Our results confirmed the findings of a cross sectional study done by
232 Mendoza-Herrera et al., who reported that higher intake of AGEs was not associated with higher
(29)
233 risk of abdominal obesity . Another study conducted by Angoorani et al., also showed that
234 there were no significant relationships between AGEs intake and general obesity, and further
235 reported significant association between AGEs intake and abdominal obesity that were related
236 to dietary energy and macronutrient intakes and after adjustment of confounding factors, this
(30)
237 relationship was lost . Abdominal obesity is one of the risk factors for the metabolic
238 syndrome, and it has been reported that patients with metabolic syndrome had a notably greater
(31)
239 consumption of dietary AGEs . In our study population, older people had lower intake of
240 AGEs.  Possibly,  it  is  because  of  the history  of metabolic  diseases  like  hypertension,
241 dyslipidemia, cardiovascular disease and following of the special diet like diet with low fat and
242 free sugar, boiled and steamed food and related recommendations that limited their AGEs intake.
243 In the present study, we also found that body composition was not different across tertiles of
244 AGEs. Poulsen et al., in a murine model, indicated no difference in body composition between
(32)
245 high and low AGEs diet groups . On the other hand, Mirmiran et al., showed there were
246 significant associations between dietary AGEs intake and BMI, waist circumference, and body
 
 
 
   
 
   
 
    
 
   
 
   
  
 
  
 
    
 
     
 
  
 
  
 
   
 
   
 
  
 
  
 
   
 
  
 
  
 
   
 
    
    
  
 
    
 
  
 
  
 
  
 
   
 
   
 
   
 
  
 
  
 
   
 
  
 
   
 
  
 
  
 
247 adiposity index in crude models, and after adjustment for possible confounders, a relationship is
(33)
248 independent of energy and macronutrient intake . Increased visceral adiposity is the important
249 indicator  of  accumulated adipose tissue,  and  is significantly  related  to  oxidative  stress
(34-36)
250 biomarkers in systemic levels . CML-AGE is harmful when it binds to RAGE, which causes
(37) 
251 a damaging cycle of chronic inflammation and production of reactive oxidative species .
252 Iranian culture includes diverse food and cooking methods. Although traditional foods do not
253 include processed products and has a higher carbohydrate content especially white rice compared
254 to fat and meat, the common cooking method is along with higher temperature and longer time
255 and also, fried onion and green vegetables is the basic item in the preparing some of the Iranian
256 food that all together can increase AGEs formation.
257 Another finding of the present study was significant decrease in BMI, WC, WHR and FFM and
258 MMI across the AGEs categories. Assessment of associations in nonlinear models is an
(38) 
259 important aspect of nutritional epidemiology ; indeed, according to our knowledge, this is the
260 first study to use nonlinear models to show this kind of relationship and we have no similar data
261 in other studies.
262 A further finding of this study was that higher intake of AGEs was associated with higher intake
263 of fat and meat and lower intake of carbohydrate. These results were in agreement with the
264 finding of Ejtahed et al., however, their results showed a decreasing intake of fiber in the highest
(39)
265 quartile of AGEs intake . It was reported that fiber contains more antioxidant content that
(40)
266 prevents AGEs formation in body .Mean dietary intake of AGEs in our study (9401kU/day)
(41)
267 was lower than cohort of healthy adults from the New York City (14700 kU/day) , which may
268 be because of differences between Iranian and Western dietary patterns. In comparison to a
269 Western diet, that includes more fat and meat foods, the Iranian population diet contains more
(42, 43)
270 complex carbohydrates and less fat and meat and lower contents of AGEs . It has been
271 observed that fat and meat include relatively greater amounts of AGEs than carbohydrates,
272 because the carbohydrate-based foods have higher water content, lower reducing sugar, and
(17)
273 higher levels of antioxidants and vitamins, which may prevent AGE formation . Additionally,
274 the difference may also be related to the dietary intake assessment tools. Although we obtained
(41)
275 dAGEs amounts by FFQ, 3-day dietary food records were used in a cohort study . Contrary to
276 our study, they included healthy people without any history of hypertension, CVD and other
277 diseases associated with inflammation and oxidative stress. The dAGEs intake in present study
278 was higher than that of reported by Mirmiran et al. in participants from Iran (7043 kU/day)
279 which may be due to the larger sample size, to use FFQ with 147 food item (vs. 168 item FFQ)
(33)
280 and characteristics of the participants such as age and living district . To be noted that,
281 comprehensive information about dAGEs intake in different population is not available.
(16)
282 It has been shown that 10% of a high AGE diet will be absorbed in the body ; however,
  
 
  
 
   
   
 
  
 
  
 
   
 
   
 
  
 
  
 
  
 
  
 
   
 
  
 
  
 
  
 
  
 
  
 
   
 
  
 
   
  
 
  
 
  
 
  
 
   
 
  
 
  
 
   
 
   
 
    
 
  
 
    
 
  
 
  
 
  
 
  
 
  
 
283 controversial data exist regarding the effects of dietary AGEs on its circulating levels. The
(22) 
284 results of some studies emphasize that intakes of CML can lead to excess serum AGE levels ,
(23)
285 whereas others show no effect of dietary AGEs on circulating levels of AGEs . Furthermore,
286 the method of cooking is very important in AGE generation; for instance, broiled chicken (5,828
287 kU/100 g) and broiled beef (5,963 kU/100 g) contain amounts of AGE, but can be considerably
288 limited (1,124 kU/100 g and 2,230 kU/100 g, respectively) by either boiling or stewing. Also the
289 use of acidic marinades, such as lemon juice and vinegar, before cooking, can decrease dAGEs
(17, 44) 
290 formation that these methods are not widely used in assessed population who are from
291 Iranian culture.
292 The modern western diet, which includes fast foods with high amount of energy, added sugar
293 and fat, has also AGEs-rich component and not only directly contributes to increase risk of
294 obesity with its high energy dense content, but also has adverse effects on weight management
(45)
295 and health through cellular mechanisms . Therefore, limiting dAGEs intake for obesity
296 prevention should be advocated. Many studies have indicated the effect of AGEs intake on
297 complications like increasing oxidative stress, diabetes, impaired kidney function, cardiovascular
(46-48)
298 disease,  are associated with abdominal obesity . Mechanisms of how dietary AGEs
299 consumption can increase obesity are not well understood yet, but one pathway is the effect of
300 AGEs on insulin resistance, where circulating insulin increases and thus promotes the storage of
301 fat, obesity, and diabetes. Dietary AGEs, such as CML, pyrraline, and pentosidine, are absorbed
(49)
302 in intestine at different rates and their pathways are not clear . Additionally, recent studies
(22, 50)
303 have shown that the dietary AGEs had no effect on circulating AGE . One prior study
304 indicated that the serum levels of CML were not a useful biomarker for estimating the
305 progression of chronic diseases, and serum levels of glyceraldehyde-derived AGEs (Glycer-
(51) 
306 AGEs) are more reliable than CML AGEs .
307 Although our study provides a much-needed insight into dAGEs and obesity, it has several
308 limitations. In Iran, there are no published food AGE databases for Iranian food, thus, we used an
309 American-based database, where only CML was measured as a marker of dietary AGEs, whilst
310 the other dietary AGEs markers, such as Glycer-AGEs, that may be an important indicator, were
311 not measured. Further, some special food items do not exist in the American-based table, and
312 thus, missing items and other items were estimated using similar foods. Moreover, the use of
313 BIA (InBody S10) for body composition evaluation, instead of more accurate methods like dual
314 energy X-ray absorptiometry (DEXA) was other important limitation, because DEXA is known
(52)
315 as a "gold standard" for this kind of measurement . Cooking methods are an important factor
316 for estimating the dietary AGEs, which has largely been ignored. Being cross-sectional in study
317 design was a further limitation, because this kind of study prevents any indication of causality
318 between AGEs intake and body composition and obesity. We used FFQ for the collection of data
319 regarding participants’ diet; however, recall bias is possible; whilst low sample size was another
320 limitation that may result in a lack of association. In addition to all this, not measuring serum
   
 
  
 
  
 
  
 
  
 
  
 
     
 
  
 
   
 
  
 
   
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 
 
  
 
  
 
   
 
   
 
  
321 AGEs level was a major limitation of present study, because it could help us to confirm if dietary
322 AGEs intake affects serum AGEs level or not. To the best of our knowledge, this is the first
323 study to have investigated association between dietary consumption of AGEs and body
324 composition measurements and obesity. Controlling for confounders was further strength of this
325 study; furthermore, we measured different components of body composition and nonlinear
326 regression was conducted to investigate nonlinear associations between exposure and outcome.
327 In summary, increasing intake of AGEs was associated with increasing intake of fat and meat. In
328 linear models, AGEs intake had not significant relation with body composition measurements
329 because of confounding variables, although nonlinear associations were found. We did not
330 observe an association between AGEs intake and odds of obesity with attention to independence
331 of dAGEs intake into energy intake in our study. However, further investigation, without all the
332 limitations of this study, particularly considering cooking methods, is needed to confirm the
333 veracity of our findings.
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Table 1. Characteristics of participants according to tertiles of AGE intakes
Table1 Tertile1
(n=88)
Tertile2
(n=89)
Tertile3
(n=88)
* 
p-value 
n % n % n %
Age(y) 0.003
Mean 40.4 35 34.4
SD 14.1 12.2 12.3
Weight(kg) 0.06
Mean 75.2 73.1 69.6
SD 17.2 16.6 13.1
Height(cm) 0.02
Mean 166 167 170
SD 10.2 9.79 9.34
2
BMI(kg/ m ) 0.09
Mean 26.1 25.9 24.7
SD 5.04 4.91 3.96
WC(cm) 0.10
Mean 91.6 89.5 87.5
SD 13.8 13.1 10.1
WHR 0.20
Mean 0.91 0.90 0.89
SD 0.07 0.06 0.05
SBP(mm Hg) 0.34
Mean 113 110 109
SD 23.9 10.2 20.6
DBP(mm Hg) 0.22
Mean 72 69.3 70.3
SD 13.5 7.78 9.52
Sex (%) 0.55
Female 53 35.8 49 33.1 46 31.1
Male 35 29.9 40 34.2 42 35.9
Education (%) 0.42
Under diploma 11 52.4 5 23.8 5 23.8
Diploma 16 32.7 16 32.7 17 34.7
Educated 61 31.3 68 34.9 66 33.8
Occupation (%) 0.56
Employee 50 35.5 46 32.6 45 31.9
Housekeeper 18 40.9 11 25 15 34.1
Retired 5 23.8 9 42.9 7 33.3
Unemployed 15 25.4 23 39 21 35.6
Marriage (%) 0.10
Single 28 24.6 45 39.5 41 36
Married 57 40.1 40 28.2 45 31.7
Divorced 1 16.7 3 50 2 33.3
Dead spouse 2 66.7 1 33.3 0 0
Life style (%) 0.59
Alone 8 33.3 10 41.7 6 25
With someone 80 33.2 79 32.8 82 34
Smoking (%) 0.46
Not smoking 77 33.6 78 34.1 74 32.3
Quit smoking 6 42.9 2 14.3 6 42.9
Smoker 5 22.7 9 40.9 8 36.4
Activity score (%) 0.71
Low 33 32.7 34 33.7 34 33.7
           
           
           
           
           
           
 
 
    
     
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moderate 41 37.3 35 31.8 34 30.9
High 14 25.9 20 37 20 37
** 
Metabolic diseases 
(%)
0.03
Yes 21 50 12 28.6 9 21.4
No 66 29.7 77 34.7 79 35.6
AGE, advanced glycation end products; SD, standard deviation; BMI, body mass index; WC, waist
circumference; WHR, waist to hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; Y,
year; Cm, centimeter; kg/m2, kilogram/meter2; mm Hg, millimeters of mercury.
* Calculated by Chi-square and analysis of variance for qualitative and quantitative variables, 
respectively. p-value is considered significant at <0.05.
**hypertension, dyslipidemia, cardiovascular disease, stroke myocardial infarction, cancer, Respiratory 
disease, osteoporosis
 
 
 
 
      
      
      
       
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
       
      
      
      
      
      
       
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
 
     
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Dietary intakes of participants according to tertiles of dietary AGE intakes
Table 2 Tertile1
(n=88)
Tertile2
(n=89)
Tertile3
(n=88)
* P-value ** p-trend 
AGE/Energy (kU/kcal) <2.96 2.96 – 4.45 4.45<
Mean 2.37 3.67 6.13
SD 0.46 0.46 1.54
Energy (kcal/d) 0.09 0.03
Mean 2179 2334 2407
SD 663 747 724
Carbohydrate (% of total energy) <0.001 <0.001
Mean 63.4 56.4 51.7
SD 5.75 6.75 6.06
Fat (% of total energy) <0.001 <0.001
Mean 23.6 29.4 36.4
SD 4.96 4.77 6.13
Protein (% of total energy) <0.001 0.02
Mean 15.1 16.3 14
SD 2.95 3.56 2.83
Total fiber (g/d) 0.40 0.18
Mean 16.4 15.6 15.1
SD 6.37 6.47 6.29
Meats group(g/d) <0.001 0.07
Mean 120 179 145
SD 63.4 123 86.4
dAGEs, dietary advanced glycation end products; EI, total energy intake; SD, standard deviation. *P value
compared the dietary intakes of participants across tertiles of AGEs using one-way analysis of variance. 
**p-trend is considered significant at <0.05
 
 
 
 
 
 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
 
      
      
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Association of dietary AGE intake and anthropometric measures and body composition.
Table 3 Tertile1
(n=88)
Tertile2
(n=89)
Tertile3
(n=88)
* P-value p-trend
** P-Ancova 
2
BMI(kg/ m ) 0.09 0.04 0.24
Mean 26.1 25.9 24.7
SD 5.04 4.91 3.96
WC(cm) 0.10 0.03 0.25
Mean 91.6 89.5 87.5
SD 13.8 13.1 10.1
WHR 0.20 0.08 0.31
Mean 0.91 0.90 0.89
SD 0.07 0.06 0.05
VFL 0.35 0.18 0.22
Mean 10.1 10 9.27
SD 4.88 4.70 4
SMM(kg) 0.23 0.09 0.60
Mean 28.8 27.7 26.9
SD 7.11 7.76 7.17
PBF(%) 0.89 0.90 0.38
Mean 30.4 30.9 30.2
SD 9.74 9.71 8.80
BFM(kg) 0.22 0.10 0.15
Mean 23.4 22.8 21
SD 10.6 9.88 7.53
FFM(kg) 0.14 0.05 0.48
Mean 51.8 50.2 48.1
SD 11.8 12.8 12.6
2
MMI(kg/ m ) 0.13 0.04 0.67
Mean 9.91 9.74 9.42
SD 1.57 1.72 1.61
TF(kg) 0.23 0.10 0.22
Mean 11.8 11.4 10.6
SD 5.17 4.84 3.84
AGE, advanced glycation end products; BMI, body mass index; SD, standard deviation; FM, fat mass; WC,
waist circumference;WHR, waist to hip ratio; VFL, visceral fat level; SMM, skeletal muscle mass; PBF, percent 
body fat; BFM, body fat mass; FFM, fat free mass; MMI, muscle mass index; TF, trunk fat.
* Calculated by analysis of variance (ANOVA) in crude model and analysis of covariance (ANCOVA) in 
adjusted models and is considered significant at <0.05.
** Adjusted for age, sex, physical activity, smoking status, education status, metabolic diseases and energy intake
  
 
 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
 
       
       
 
 
 
 
 
  
 
Table 4. Odds ratios (95% confidence interval) for general and central obesity according to
categories of dAGEs
Tertile1
(n=88)
* P value Tertile2
(n=89)
P value Tertile3
(n=88)
P value
General obesity
2
BMI ≥ 30 kg/ m
Crude 1 reference 0.12 1.34(0.62-2.89) 0.45 0.52(0.21-1.33) 0.17
Model 1 1 reference 0.22 1.30(0.57-2.94) 0.52 0.57(0.21-1.51) 0.26
Model 2 1 reference 0.12 1.31(0.57-3.03) 0.52 0.47(0.17-1.30) 0.14
Model 3 1 reference 0.12 1.32(0.56-3.09) 0.51 0.47(0.17-1.30) 0.15
Central obesity
Men
WC≥ 102cm
Women
WC≥ 88cm
Crude 1 reference 0.27 0.80(0.43-1.49) 0.49 0.59(0.31-1.12) 0.11
Model 1 1 reference 0.21 0.75(0.39-1.43) 0.39 0.55(0.28-1.07) 0.07
Model 2 1 reference 0.15 0.76(0.39-1.47) 0.41 0.50(0.25-1.00) 0.05
Model 3 1 reference 0.14 0.77(0.39-1.51) 0.45 0.50(0.25-1.00) 0.05
Men
WHR>0.9
Women
WHR>0.85
Crude 1 reference 0.66 1.25(0.66-2.36) 0.48 0.95(0.51-1.77) 0.87
Model 1 1 reference 0.73 1.26(0.64-2.47) 0.49 1.00(0.51-1.93) 0.99
Model 2 1 reference 0.72 1.22(0.61-2.42) 0.56 0.93(0.47-1.85) 0.85
Model 3 1 reference 0.68 1.25(0.62-2.50) 0.52 0.93(0.46-1.85) 0.83
VFL≥10
Crude 1 reference 0.25 0.81(0.45-1.47) 0.49 0.60(0.33-1.09) 0.09
Model 1 1 reference 0.16 0.74(0.39-1.42) 0.37 0.53(0.27-1.02) 0.05
Model 2 1 reference 0.11 0.72(0.37-1.40) 0.34 0.48(0.24-0.95) 0.03
Model 3 1 reference 0.10 0.73(0.37-1.42) 0.35 0.47(0.24-0.94) 0.03
BFM(kg)≥21.9
Crude 1 reference 0.31 0.85(0.47-1.53) 0.59 0.63(0.34-1.14) 0.13
Model 1 1 reference 0.26 0.79(0.42-1.50) 0.48 0.58(0.30-1.11) 0.10
Model 2 1 reference 0.21 0.79(0.41-1.53) 0.50 0.55(0.28-1.07) 0.08
Model 3 1 reference 0.20 0.80(0.41-1.56) 0.52 0.54(0.27-1.07) 0.07
AGE, advanced glycation end products; BMI, body mass index; WC, waist circumference; WHR, waist to 
hip ratio; VAT, visceral fat level; BFM, fat mass.
  
 
  
 
   
 
  
 
 
 
 
   
    
 
 
 
 
 
 
 
      
 
 
  
 
   
    
 
 
  
  
 
 
 
 
       
 
 
 
 
   
   
 
 
 
       
 
 
  
 
 
 
 
 
 
 
  
* P values are reported based on the logistic regression test and are considered significant at ˂0.05 
Model 1: adjusted for age and sex
Model 2: model 1 + physical activity, smoking status, education status and metabolic diseases
Model 3: model 2 + energy intake
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Fig 1. linear and nonlinear relations between AGEs intake and body composition measures
dAGEs, dietary advanced glycation end products; EI, total energy intake; BMI, body mass 
index; WC, waist circumference; WHR, waist to hip ratio; VFL, visceral fat level; SMM, 
skeletal muscle mass; PBF, percent body fat; BFM, body fat mass; FFM, fat free mass; MMI, 
muscle mass index; TF, trunk fat.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
      
      
       
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
       
      
      
      
      
      
      
      
      
      
      
      
      
      
       
      
      
      
      
      
      
      
      
      
 
Supplementary Table 1. Dietary intakes of participants according to tertiles of dietary AGE intakes
Tertile1
(n=88)
Tertile2
(n=89)
Tertile3
(n=88)
* P-value ** p-trend 
AGE/Energy (kU/kcal) <2.96 2.96 – 4.45 4.45<
Mean 2.37 3.67 6.13
SD 0.46 0.46 1.54
Energy (kcal/d)
Male 0.06 0.03
Mean 2326 2651 2698
SD 748 720 744
Female 0.85 0.65
Mean 2082 2075 2140
SD 588 670 598
Carbohydrate (% of total energy)
Male <0.001 <0.001
Mean 64.6 56.4 52.3
SD 6.12 7.58 5.49
Female <0.001 <0.001
Mean 62.6 56.5 51
SD 5.41 6.07 6.54
Fat (% of total energy)
Male <0.001 <0.001
Mean 21.9 28.5 34.2
SD 4.52 4.71 5.20
Female <0.001 <0.001
Mean 24.7 30.2 38.3
SD 4.96 4.71 6.31
Protein (% of total energy)
Male 0.04 0.93
Mean 15.3 17 15.2
SD 3.01 4.06 3.22
Female <0.001 <0.001
 
 
 
 
 
 
 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
 
 
Mean 15 15.7 13
SD 2.93 3.03 1.93
Total fiber (g/d)
Male 0.92 0.77
Mean 16.3 16.9 16.8
SD 5.77 6.81 7.09
Female 0.06 0.02
Mean 16.4 14.5 13.5
SD 6.79 6.02 5.06
Meats group(g/d)
Male 0.002 0.05
Mean 138 228 185
SD 66.8 145 95.6
Female 0.03 0.97
Mean 108 140 109
SD 58.9 85 57.1
dAGEs, dietary advanced glycation end products; SD, standard deviation. *P value compared the dietary 
intakes of participants across tertiles of AGEs using one-way analysis of variance. **p-trend is considered 
significant at <0.05
 
 
 
 
 
 
 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
Supplementary Table 2. Association of dietary AGE intake and anthropometric measures and body
composition.
Tertile1
(n=88)
Tertile2
(n=89)
Tertile3
(n=88)
* P-value p-trend
** P-Ancova 
2
BMI(kg/ m )
Male 0.47 0.24 0.28
Mean 26.7 26.4 25.5
SD 4.78 4.15 2.86
Female 0.30 0.19 0.46
Mean 25.5 25.5 24.2
SD 5.28 5.49 4.42
WC(cm)
Male 0.35 0.16 0.17
Mean 95.8 92.9 92
SD 14.2 12.7 8.42
Female 0.54 0.28 0.67
Mean 87.5 86.7 85
SD 12.3 12.9 10.2
WHR
Male 0.33 0.21 0.20
Mean 0.93 0.91 0.91
SD 0.07 0.07 0.06
Female 0.80 0.51 0.85
Mean 0.89 0.89 0.88
SD 0.06 0.05 0.05
VFL
Male 0.23 0.09 0.15
Mean 9.30 8.56 7.62
SD 4.70 4.30 3.30
Female 0.41 0.34 0.58
Mean 11 11.3 10.2
SD 4.96 4.69 4.08
SMM(kg)
Male
Mean 34.5 34.3 34.9 0.90 0.77 0.95
SD 5.25 5.79 4.70
Female 0.22 0.16 0.37
Mean 23.2 22.1 22.3
SD 3.21 3.74 3.22
PBF(%)
Male 0.36 0.16 0.30
Mean 25.3 24.5 22.7
SD 8.24 8.37 6.98
Female 0.45 0.63 0.67
Mean 35.2 36.3 34.5
  
 
 
 
 
 
 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
 
   
     
   
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SD 8.62 7.12 6.60
BFM(kg)
Male 0.22 0.08 0.10
Mean 22.1 20.5 18.4
SD 10.3 9.69 6.49
Female 0.39 0.27 0.51
Mean 24.6 24.8 22.5
SD 10.7 9.70 7.70
FFM(kg)
Male 0.94 0.84 0.93
Mean 61.3 61 61.7
SD 8.89 9.74 7.69
Female 0.15 0.06 0.25
Mean 42.8 40.9 40.4
SD 5.47 6.24 7.19
2
MMI(kg/ m )
Male 0.99 0.90 0.86
Mean 11 11 11.1
SD 1.16 1.17 1.07
Female 0.27 0.10 0.43
Mean 8.80 8.60 8.46
SD 1 1.21 0.95
TF(kg)
Male 0.30 0.12 0.15
Mean 11.6 10.7 9.89
SD 5.46 4.95 3.68
Female 0.45 0.32 0.61
Mean 11.9 12 11
SD 4.94 4.71 3.90
AGE, advanced glycation end products; BMI, body mass index; SD, standard deviation; FM, fat mass; WC, waist
circumference; WHR, waist to hip ratio; VFL, visceral fat level; SMM, skeletal muscle mass; PBF, percent body fat;
BFM, body fat mass; FFM, fat free mass; MMI, muscle mass index; TF, trunk fat.
* Calculated by analysis of variance (ANOVA) in crude model and analysis of covariance (ANCOVA) in adjusted
models and is considered significant at <0.05.
** Adjusted for age, sex, physical activity, smoking status, education status, metabolic diseases and energy intake
